Navigation Links
Gene-Eden-VIR is Most Cost Effective; polyDNA Compares Treatments for Herpes Infection
Date:4/25/2013

Rochester, NY (PRWEB) April 25, 2013

polyDNA recommends Gene-Eden-VIR as the most cost effective means of treating a latent herpes infection. During Money Smart Week (1), polyDNA is doing its part by contrasting the cost of Herpes treatments. One of those treatments is Gene-Eden-VIR, a natural remedy against the latent herpes virus.

This week, the media, government agencies, not-for-profits, schools, financial institutions and businesses of all kinds are working together to help customers manage their personal finances better. To help customers who suffer from herpes infections, polyDNA compared the cost of Valtrex, Acyclovir (Zovirax), and Gene-Eden-VIR. The first two are FDA approved medications while the third is a natural, antiviral remedy.

“I used to take Valtrex daily, but then I lost my insurance and could no longer afford a month’s supply. Taking care of my outbreaks has just been so hard since that happened. I’m looking around, constantly trying to find a way to save on herpes medications. I hate it that I have needs and I can’t afford to cover them on my own.” – Jenna R.

According to herpesnews.com, the cost of a month’s supply of Valtrex (90 pills), one of the most common anti-herpes medications, is $1275 for the brand name at the CVS Pharmacy. (2) The cost of the generic brand is only slightly less.

While Acyclovir (Zovirax) is significantly cheaper, this herpes medication still costs at least $140.00 for 90 pills. (2)

Gene-Eden-VIR is an antiviral remedy that boosts the immune system against the latent herpes viruses. A month’s supply of Gene-Eden-VIR is $37.99. That’s $102.01 cheaper than Zovirax, and well over $1,000 cheaper than Valtrex.

In a post marketing clinical study, Gene-Eden-VIR was shown to be safe and highly effective against the latent herpes viruses. Over 70% of Gene-Eden-VIR users reported a reduction in herpes symptoms. (3)

Gene-Eden-VIR is highly effective against the latent herpes viruses, each ingredient was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of HSV. (4)

To learn more about Gene-Eden-VIR, the only product on the market today that helps the body target the latent HPV virus and that is scientifically backed by published material, visit http://www.gene-eden-kill-virus.com.

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com.

References:

(1)    http://www.moneysmartweek.org/
(2)    http://herpesnews.com/herpes-medications/price-comparison-between-valtrex-generic-valtrex-and-acyclovir-in-united-states/
(3)    http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(4)    http://www.gene-eden-kill-virus.com/studies.php

###

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10661353.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome
2. Study Says Kidney Bean Leaves Work Against Bed Bugs, My Cleaning Products Compares Its With a Non-Pesticide Bed Bug Spray
3. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
4. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
5. Atlanta LASIK Surgeon Dr. Ashraf Releases YouTube Videos Featuring Patient Testimonials and Discussion of Common Eye Treatments
6. Lung Cancer Survivors Share Stories of Value of Early Detection and Hope for More Effective Treatments
7. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
8. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
9. Bacterias hidden skill could pave way for stem cell treatments
10. Find New Cancer Treatments at cureLauncher
11. American Heart Month: Find New Heart Disease Treatments on cureLauncher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... PA (PRWEB) , ... May 02, 2016 , ... ... proud to report on the pre-launch success of their revolutionary, veterinarian-designed product for ... cats to stalk, trap, and play with their food the way nature intended. ...
(Date:4/29/2016)... ... April 30, 2016 , ... The MIT bioLogic design team has won ... explored how bacterial properties can be applied to fabric and formed into living interfaces ... in response to humidity change. The team harvested Natto cells and applied them to ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... medicine, is excited to announce the launch of the Proove Health Foundation ... volunteerism, and education to promote the use of personalized medicine for tackling the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Amendia, Inc., ... surgical procedures, today announced the completion of a significant transaction and partnership that ... future customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), a leading private ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
Breaking Biology News(10 mins):